The Hidden Link Between Sex, Chronic Kidney Disease (CKD) and Medial Arterial Calcification (MAC)

Study Lead

Dr. Marta Cerruti

McGill University

Overview

· Patients with chronic kidney disease (CKD) have a greater risk of heart and vascular health issues as well.

· Medial arterial calcification (MAC) affects up to 80% of CKD patients and causes the arteries to stiffen which can lead to further cardiovascular and kidney health complications if left untreated.

· MAC is still poorly understood in CKD patients, especially the potential differences between men and women.

Both kidney disease and cardiovascular disease can have sex-specific differences in development and presentation, making it crucial to understand these differences to inform earlier diagnosis and develop better treatments.

Researchers at McGill University are looking to address this gap in our knowledge and need your help to do so. They are looking for persons with lived experience to collaborate on their research and provide an important patient perspective to ensure their research is relevant to the patient community.

As a patient partner, you will be asked to review current study materials and participate in a minimum of one 1-hour meeting with the research team (in person or virtual). Follow up with the research team will be done regularly after the project is funded.

As a patient partner, you will help:

· Inform research questions and priorities

· Strengthen grant applications

· Discuss results when available

· Help knowledge translation (including the opportunity to collaborate on published papers)

Eligibility

· Have kidney disease and a cardiovascular health condition(s)

· Located in Canada

Participating can be done in English or French.

Type of Participation

Patient Partnership

Diagnosis

Acute Kidney Injury, Chronic Kidney Disease, Glomerulonephritis, Nephrotic Syndrome, Pediatric Kidney Disease, Polycystic Kidney Disease

Related Condition

Heart Disease

Treatment

Transplantation

Topic

Peer Support, Prevention, Quality of Life, Symptoms

Location

Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland & Labrador, Northwest Territories, Nova Scotia, Nunavut, Ontario, Prince Edward Island, Quebec, Saskatchewan, Yukon

Related studies

  • Kidney Transplant Stakeholders’ Perspectives on the Future of Xenotransplantation in Canada

    Overview:

    Study type: Focus Group, Interview

    January 7, 2026

  • A qualitative study exploring patient and caregiver perspectives and experiences on disaster management in kidney care

    Overview:

    Study type: Interview

    January 7, 2026

  • Equitable Pandemic Communication Strategies to Support Sexual and Gender Minority Transplant Patients

    Overview:

    Study type: Interview

    December 4, 2025